MGS Manufacturing Group Inc. is investing more than $2.7 million to construct and equip a Class 100,000 clean room at one of its Germantown, Wis., plants.
With continual growth at our medical molding facility in Antioch, Ill., and steady growth within the medical industry as a whole, we determined that now is the right time to expand our clean room molding capabilities, said Jeff Kolbow, chief operating officer of Germantown-based MGS.
The addition will allow us to enhance our manufacturing and value-added services for existing and prospective customers in the health-care market, Kolbow said in a news release.
MGS expects to complete construction and obtain Class 100,000 certification by June. The injection molder is working toward obtaining ISO 13485 certification during mid-2010.
The 6,250-square-foot clean room is being constructed within the south bay of a 186,000-square-foot facility currently used for molding operations, said marketing director John Berg. It is the first clean room for MGS in Wisconsin. We have an existing [Class 100,000] clean room for molding and assembly in our Antioch facility, Berg said.
The clean room will be scalable to roughly twice the square footage, as demand dictates.
Maintaining the original ceiling height will allow the plant to use its 10-ton overhead crane system. This will facilitate our ability to run tooling systems with higher cavitations, Berg said via e-mail. The greater overhead space also allows MGS to easily retrofit injection molding machines with our vertically mounted (proprietary) Universal Multishot Systems portable injection units.
Each injection press in the new clean room will be multishot capable, including any new machines purchased.
We are anticipating approximately eight to 14 presses in the 50- to 500-ton range, Berg said. We are currently evaluating the potential of new press purchases.
Automation equipment will facilitate post-mold value-added operations.
The budget for the construction of the facility-within-a-facility clean room is in the $1.2 million to $1.4 million range, Berg said. While all the manufacturing equipment decisions have not been made, we estimate an additional $1.5 million to $2 million investment.
For the medical and health-care sector, MGS has manufactured products for diagnostic, transfusion therapy and drug-delivery applications and diabetic care including luer fittings, connectors, disposable plastic cannula, components for disposable transfusion therapy sets, single-use liquid injectable delivery devices, housings, and lancet and glucose metering devices.
MGS employs about 800 at four facilities in Germantown and plants in Antioch; Menomonee Falls, Wis.; Libertyville, Ill.; and Chihuahua, Mexico.
For the fiscal year ended Sept. 30, MGS had sales of about $110 million, with about 65 percent from molding operations, 30 percent from tooling and 0.5 percent from equipment.
Consumer items accounted for about 25 percent of revenue, medical and health care 20 percent and electronics 15 percent. Other end markets include automotive, packaging and industrial/construction.
Copyright 2010 Crain Communications Inc. All Rights Reserved.